Mutschler E - Search Results

1

Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs.

Lipka E, Lee ID, Langguth P, Spahn-Langguth H, Mutschler E, Amidon GL. Lipka E, et al. Among authors: mutschler e. J Pharmacokinet Biopharm. 1995 Jun;23(3):267-86. doi: 10.1007/BF02354285. J Pharmacokinet Biopharm. 1995. PMID: 8834196 Free article.

2

In vivo non-linear intestinal permeability of celiprolol and propranolol in conscious dogs: evidence for intestinal secretion.

Lipka E, Spahn-Langguth H, Mutschler E, Amidon GL. Lipka E, et al. Among authors: mutschler e. Eur J Pharm Sci. 1998 Jan;6(1):75-81. doi: 10.1016/s0928-0987(97)00070-5. Eur J Pharm Sci. 1998. PMID: 16256710

3

Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function.

Hartmann C, Frölich M, Krauss D, Spahn-Langguth H, Knauf H, Mutschler E. Hartmann C, et al. Among authors: mutschler e. Eur J Clin Pharmacol. 1990;39(6):573-6. doi: 10.1007/BF00316098. Eur J Clin Pharmacol. 1990. PMID: 1982763

4

[Transdermal therapeutic systems].

Mutschler E, Langguth P. Mutschler E, et al. Fortschr Med. 1987 Oct 10;105(29):571-4. Fortschr Med. 1987. PMID: 3679053 German. No abstract available.

5

A new rapid and sensitive high-performance liquid chromatographic assay for diclofenac in human plasma.

Hanses A, Spahn-Langguth H, Mutschler E. Hanses A, et al. Among authors: mutschler e. Arch Pharm (Weinheim). 1995 Mar;328(3):257-60. doi: 10.1002/ardp.19953280309. Arch Pharm (Weinheim). 1995. PMID: 7763141

6

Predictions of in vivo plasma concentrations from in vitro release kinetics: application to doxepin parenteral (i.m.) suspensions in lipophilic vehicles in dogs.

Gido C, Langguth P, Mutschler E. Gido C, et al. Among authors: mutschler e. Pharm Res. 1994 Jun;11(6):800-8. doi: 10.1023/a:1018913321164. Pharm Res. 1994. PMID: 7937517

7

Pharmacokinetics of dilevalol and its conjugates in man. Assay method for plasma, blood, urine and bile samples and preliminary pharmacokinetic studies.

Neubeck M, Becker C, Henke D, Rösch W, Spahn-Langguth H, Mutschler E. Neubeck M, et al. Among authors: mutschler e. Arzneimittelforschung. 1993 Sep;43(9):953-7. Arzneimittelforschung. 1993. PMID: 8240457

8

Predictability of the covalent binding of acidic drugs in man.

Benet LZ, Spahn-Langguth H, Iwakawa S, Volland C, Mizuma T, Mayer S, Mutschler E, Lin ET. Benet LZ, et al. Among authors: mutschler e. Life Sci. 1993;53(8):PL141-6. doi: 10.1016/0024-3205(93)90279-c. Life Sci. 1993. PMID: 8350674 Review.

9

Pharmacokinetics of beclobric acid enantiomers and their conjugates after single and multiple oral dosage of racemic beclobrate.

Mayer S, Spahn-Langguth H, Gikalov I, Mutschler E. Mayer S, et al. Among authors: mutschler e. Arzneimittelforschung. 1993 Jan;43(1):40-3. Arzneimittelforschung. 1993. PMID: 8447845

10

Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo.

Wetterich U, Spahn-Langguth H, Mutschler E, Terhaag B, Rösch W, Langguth P. Wetterich U, et al. Among authors: mutschler e. Pharm Res. 1996 Apr;13(4):514-22. doi: 10.1023/a:1016029601311. Pharm Res. 1996. PMID: 8710739 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters